CLINICAL_TRIALS
trial_result
· 2025-07-25
Clinical Trial Update: Personalized Medicine for Membranous Nephropathy [Phase 2]
Summary
The document reports the completion of a Phase 2 clinical trial investigating personalized medicine for idiopathic membranous nephropathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Idiopathic Membranous Nephropathy | Phase 2 | Status: COMPLETED